In its ongoing investment push, Merck KGaA will pour 130 million euros ($132 million) into beefing up the ability of its manufacturing arm—MilliporeSigma—to employ single-use assemblies at its ...

Under the terms of the agreement, Biocytogen will provide proprietary, fully human antibodies derived from its RenMice ® platform for evaluation in Merck’s antibody-conjugated LNP services. Merck has ...

Megan Cerullo is a New York-based reporter for CBS MoneyWatch covering small business, workplace, health care, consumer spending and personal finance topics. She regularly appears on CBS News 24/7 to ...

Merck, a leading science and technology company, today announced the appointment of David Weinreich, MD, MBA, as Global Head of R&D and Chief Medical Officer for its Healthcare business sector.